Glaxo Group Limited, UK has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
GLAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Glaxo Group Limited, UK, the promoter of GlaxoSmithKline Pharmaceuticals, has submitted a copy of its disclosure under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 to the stock exchange. This regulation relates to disclosures by promoters regarding encumbered (pledged) shares in the company. The specific details of the disclosure — whether it pertains to creation, release, or invocation of a pledge — are not provided in the headline.
This is a routine regulatory compliance filing by the promoter regarding its share encumbrance status. Investors should check the attached disclosure for any change in the number of pledged shares, which could affect perceptions of promoter financial health, though such filings are often routine with no material change.